Cardiac Tumors: JACC CardioOncology State-of-the-Art Review

S Tyebally, D Chen, S Bhattacharyya, A Mughrabi… - Cardio Oncology, 2020 - jacc.org
Cardiac masses are rare, but remain an important component of cardio-oncology practice.
These include benign tumors, malignant tumors (primary and secondary) and tumor-like …

Carcinoid heart disease

S Bhattacharyya, J Davar, G Dreyfus, ME Caplin - Circulation, 2007 - Am Heart Assoc
Carcinoid heart valves demonstrate accumulation of tissue growth factor-ß latency–
associated peptide and latent binding protein. 15 5-HT has been shown to increase …

Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement

J Davar, HM Connolly, ME Caplin, M Pavel… - Journal of the American …, 2017 - jacc.org
Carcinoid heart disease is a frequent occurrence in patients with carcinoid syndrome and is
responsible for substantial morbidity and mortality. The pathophysiology of carcinoid heart …

Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography

DX Augustine, LD Coates-Bradshaw, J Willis… - Echo Research & …, 2018 - Springer
Pulmonary hypertension is defined as a mean arterial pressure of≥ 25 mmHg as confirmed
on right heart catheterisation. Traditionally, the pulmonary arterial systolic pressure has …

Features of carcinoid heart disease identified by 2-and 3-dimensional echocardiography and cardiac MRI

S Bhattacharyya, C Toumpanakis, M Burke… - Circulation …, 2010 - Am Heart Assoc
Background—Carcinoid heart disease is a rare form of valvular heart disease. We sought
describe the spectrum of carcinoid heart disease identified by echocardiography and …

Usefulness of N-terminal pro–brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease

S Bhattacharyya, C Toumpanakis, ME Caplin… - The American journal of …, 2008 - Elsevier
We sought to investigate whether N-terminal pro–brain natriuretic peptide (NT–pro-BNP)
can be used as a biomarker for the detection of carcinoid heart disease (CHD); 200 patients …

Risk factors for the development and progression of carcinoid heart disease

S Bhattacharyya, C Toumpanakis, D Chilkunda… - The American journal of …, 2011 - Elsevier
The development of valvular heart disease in patients with carcinoid syndrome is thought to
be related to the secretion of vasoactive substances by a tumor. We sought to identify …

Radiation-induced valvular heart disease

DM Gujral, G Lloyd, S Bhattacharyya - Heart, 2016 - heart.bmj.com
Radiation to the mediastinum is a key component of treatment with curative intent for a range
of cancers including Hodgkin's lymphoma and breast cancer. Exposure to radiation is …

Drug-induced fibrotic valvular heart disease

S Bhattacharyya, AH Schapira, DP Mikhailidis, J Davar - The Lancet, 2009 - thelancet.com
The initial association between the development of valvular heart disease and drugs stems
from observations made during the use of methysergide and ergotamine for migraine …

Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century

S Bhattacharyya, C Toumpanakis, ME Caplin… - The American journal of …, 2008 - Elsevier
Carcinoid heart disease (CHD), reported in 50% to 70% of patients with carcinoid syndrome,
is thought to be related to the production of 5-hydroxytryptamine by the tumor. The …